Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuanguang Liu, Qing Chang, Xiaotang Wu, Youlin Yu & Huizhong Zhang. (2022) Effect of chemokine CXCL14 on in vitro angiogenesis of human hepatocellular carcinoma cells. Archives of Physiology and Biochemistry 128:5, pages 1316-1322.
Read now
Read now
Dongzhi Cen, Gang Hu, Yubing Zhou, Lijian Yang, Shaohua Chen, Christian A. Schmidt & Yangqiu Li. (2010) Enhancement of specific cellular immune response induced by DNA vaccines encoding PML-RARα and hIL-2 genes. Hematology 15:2, pages 88-95.
Read now
Read now
Articles from other publishers (19)
Brian Z Huang, Alexandra M Binder, Catherine A Sugar, Chun R Chao, Veronica Wendy Setiawan & Zuo-Feng Zhang. (2020) Methylation of immune-regulatory cytokine genes and pancreatic cancer outcomes. Epigenomics 12:15, pages 1273-1285.
Crossref
Crossref
Yichen Wang, Qicheng Ni, Jiajun Sun, Min Xu, Jing Xie, Jun Zhang, Yuan Fang, Guang Ning & Qidi Wang. (2020) Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer. The Journal of Clinical Endocrinology & Metabolism 105:4, pages e1489-e1503.
Crossref
Crossref
Madanraj Appiya Santharam & Vignesh Dhandapani. 2019. Exploring Pancreatic Metabolism and Malignancy. Exploring Pancreatic Metabolism and Malignancy
133
156
.
Saeed Farajzadeh Valilou, Mahsa Keshavarz-Fathi, Nicola Silvestris, Antonella Argentiero & Nima Rezaei. (2018) The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer. Cytokine & Growth Factor Reviews 39, pages 46-61.
Crossref
Crossref
Zu T. Shen & Alexander B. Sigalov. (2017) Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer. Molecular Pharmaceutics 14:12, pages 4572-4582.
Crossref
Crossref
Yang Liu, Fan Li, Feng Gao, Lingxi Xing, Peng Qin, Xingxin Liang, Jiajie Zhang, Xiaohui Qiao, Lizhou Lin, Qian Zhao & Lianfang Du. (2016) Role of microenvironmental periostin in pancreatic cancer progression. Oncotarget 8:52, pages 89552-89565.
Crossref
Crossref
Somala Mohammed, Sujita Sukumaran, Pradip Bajgain, Norihiro Watanabe, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, William E. Fisher, Ann M. Leen & Juan F. Vera. (2017) Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Molecular Therapy 25:1, pages 249-258.
Crossref
Crossref
Sònia Bassagañas, Helena Allende, Lara Cobler, M. Rosa Ortiz, Esther Llop, Carme de Bolós & Rosa Peracaula. (2015) Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines. Cytokine 75:1, pages 197-206.
Crossref
Crossref
S M Wörmann, K N Diakopoulos, M Lesina & H Algül. (2013) The immune network in pancreatic cancer development and progression. Oncogene 33:23, pages 2956-2967.
Crossref
Crossref
Pengjun Zhang, Meng Zou, Xinyu Wen, Feng Gu, Juan Li, Gaixia Liu, Jingxiao Dong, Xinxin Deng, Jing Gao, Xiaolong Li, Xingwang Jia, Zhennan Dong, Luonan Chen, Yong Wang & Yaping Tian. (2014) Development of serum parameters panels for the early detection of pancreatic cancer. International Journal of Cancer 134:11, pages 2646-2655.
Crossref
Crossref
Rozita Roshani, Fiona McCarthy & Thorsten Hagemann. (2014) Inflammatory cytokines in human pancreatic cancer. Cancer Letters 345:2, pages 157-163.
Crossref
Crossref
Naotake Funamizu, Chaoxin Hu, Curtis Lacy, Aaron Schetter, Geng Zhang, Peijun He, Jochen Gaedcke, Michael B. Ghadimi, Thomas Ried, Harris G. Yfantis, Dong H. Lee, Jeffrey Subleski, Tim Chan, Jonathan M. Weiss, Timothy C. Back, Katsuhiko Yanaga, Nader Hanna, H. Richard Alexander, Anirban Maitra & S. Perwez Hussain. (2012) Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. International Journal of Cancer 132:4, pages 785-794.
Crossref
Crossref
Dong-Youl ChoiRan HongSung-Churl LimKeun-Hong KeeChae-Hong SuhMija Lee. (2011) Prognostic Implications of the Expression of CXCL16 in Breast Carcinoma. The Korean Journal of Pathology 45:1, pages 15.
Crossref
Crossref
Ying Chen, Guanzhen Yu, Danghui Yu & Minghua Zhu. (2010) PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Crossref
M. Dandrea, M. Donadelli, C. Costanzo, A. Scarpa & M. Palmieri. (2009) MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Research 37:20, pages 6681-6690.
Crossref
Crossref
Buckminster Farrow, David Rowley, Truong Dang & David H. Berger. (2009) Characterization of Tumor-Derived Pancreatic Stellate Cells. Journal of Surgical Research 157:1, pages 96-102.
Crossref
Crossref
Markus Stenner & J. Peter Klussmann. (2008) Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. European Archives of Oto-Rhino-Laryngology 266:3, pages 333-341.
Crossref
Crossref
Letizia Scola, Antonio Giacalone, Lorenzo Marasà, Monica Mirabile, Loredana Vaccarino, Giusi Irma Forte, Lydia Giannitrapani, Calogero Caruso, Giuseppe Montalto & Domenico Lio. (2009) Genetic Determined Downregulation of Both Type 1 and Type 2 Cytokine Pathways Might Be Protective against Pancreatic Cancer. Annals of the New York Academy of Sciences 1155:1, pages 284-288.
Crossref
Crossref
Moritz N. Wente, Christine Mayer, Matthias M. Gaida, Christoph W. Michalski, Thomas Giese, Frank Bergmann, Nathalia A. Giese, Markus W. Büchler & Helmut Friess. (2008) CXCL14 expression and potential function in pancreatic cancer. Cancer Letters 259:2, pages 209-217.
Crossref
Crossref